ArticleCADTH technology overviews2010

Long-acting beta(2)-agonist and inhaled corticosteroid combination therapy for adult persistent asthma: systematic review of clinical outcomes and economic evaluation.

Canadian Agency for Drugs and Technologies in Health (CADTH)PubMed ↗Full text ↗

No numbers read from the abstract.